【24h】

Inhibitory Mechanism of SN-6, A Novel Benzyloxyphenyl Na~+/Ca~(2+) Exchange Inhibitor

机译:新型苄氧基苯基Na〜+ / Ca〜(2+)交换抑制剂SN-6的抑制机理

获取原文
获取原文并翻译 | 示例

摘要

We investigated the pharmacological properties of SN-6, a new selective Na~+/Ca~(2+) exchanger (NCX) inhibitor. SN-6 preferentially inhibited the ~(45)Ca~(2+) uptake via NCX compared with the ~(45)Ca~(2+) efflux via NCX in NCX-transfected fibroblasts. SN-6 was three- to fivefold more inhibitory to the ~(45)Ca~(2+) uptake via NCX1 (IC_(50) = 2.9 μM) than to that via NCX2 or NCX3. Our chimeric and site-directed mutageneses revealed that Phe-213, Val-227, Tyr-228, Gly-833, and Asn-839 in NCX1 are molecular determinants for interaction with SN-6. We also found that SN-6 potently protects against hypoxia/reoxygenation-induced cell damage in renal tubular cells.
机译:我们研究了一种新型的选择性Na〜+ / Ca〜(2+)交换剂(NCX)抑制剂SN-6的药理特性。与NCX转染的成纤维细胞通过NCX的〜(45)Ca〜(2+)外排相比,SN-6优先抑制了通过NCX的〜(45)Ca〜(2+)吸收。 SN-6通过NCX1(IC_(50)= 2.9μM)抑制〜(45)Ca〜(2+)的吸收是通过NCX2或NCX3抑制的三到五倍。我们的嵌合和定点突变显示,NCX1中的Phe-213,Val-227,Tyr-228,Gly-833和Asn-839是与SN-6相互作用的分子决定因素。我们还发现SN-6可以有效防止缺氧/复氧诱导的肾小管细胞损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号